CoImmune, Inc. Announces Research Collaboration with Yeda Research and Development Company Ltd.
The agreement will support research on applications of the Synthetic Immune Niche technology, developed at the Weizmann Institute of Science and commercialized by Yeda, the commercial arm of the Weizmann Institute, in novel immunotherapies based on CoImmune’s CAR-CIK platform. DURHAM, N.C., Nov. 17, 2021 (GLOBE NEWSWIRE) — CoImmune, Inc., a